MCM
AGN

Mazama Capital Management’s Allergan plc AGN Stock Holding History

Mazama Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,797
Closed -$2.44M – 214
2015
Q4 		$2.44M Sell
7,797
-619
-7% -$184K 0.45% 65
2015
Q3 		$2.29M Sell
8,416
-17,289
-67% -$5.31M 0.47% 57
2015
Q2 		$7.8M Buy
25,705
+10,548
+70% +$3.15M 1.57% 10
2015
Q1 		$4.51M Buy
15,157
+5,401
+55% +$1.54M 0.93% 34
2014
Q4 		$2.51M Buy
9,756
+6,382
+189% +$1.6M 0.58% 58
2014
Q3 		$814K Sell
3,374
-11,583
-77% -$2.59M 0.21% 137
2014
Q2 		$3.34M Buy
14,957
+14,669
+5,093% +$3.04M 0.89% 37
2014
Q1 		$59K Sell
288
-5,679
-95% -$1.12M 0.05% 125
2013
Q4 		$1M Sell
5,967
-1,100
-16% -$172K 0.5% 86
2013
Q3 		$1.02M Buy
7,067
+167
+2% +$22.2K 0.56% 71
2013
Q2 		$871K Buy
+6,900
New +$781K 0.54% 71

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Mazama Capital Management's AGN Position: Q1 2016 in Review

Mazama Capital Management sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 7,797 shares — an estimated $2.44M sold.

Mazama Capital Management first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $7.8M in Q2 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Mazama Capital Management reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Mazama Capital Management sold 7,797 Allergan plc shares in Q1 2016, an estimated $2.44M.
  • Mazama Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
  • Mazama Capital Management's Allergan plc position peaked at $7.8M in Q2 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.